PFM Health Sciences, LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$20,091,000
-37.3%
3,512,3480.0%0.75%
-31.2%
Q4 2021$32,068,000
+0.2%
3,512,348
+17.3%
1.09%
+16.0%
Q3 2021$32,001,000
-6.2%
2,993,546
+36.1%
0.94%
-12.1%
Q2 2021$34,129,000
-13.1%
2,199,057
-9.2%
1.07%
-10.8%
Q1 2021$39,272,000
-7.8%
2,422,678
+20.4%
1.20%
-20.0%
Q4 2020$42,573,000
+53.5%
2,011,477
+7.5%
1.50%
+16.8%
Q3 2020$27,743,000
-15.5%
1,872,012
-16.1%
1.28%
-24.7%
Q2 2020$32,824,000
+12.7%
2,231,402
-10.1%
1.70%
-28.8%
Q1 2020$29,138,000
-57.8%
2,481,917
+39.6%
2.39%
+121.4%
Q2 2018$69,056,000
+49.1%
1,777,500
-46.9%
1.08%
-13.4%
Q2 2017$46,322,000
-21.5%
3,344,517
-15.0%
1.25%
-15.5%
Q1 2017$58,991,000
+64.8%
3,932,730
+43.9%
1.48%
+46.4%
Q4 2016$35,806,000
-38.7%
2,733,277
-19.4%
1.01%
-41.0%
Q3 2016$58,414,000
-3.4%
3,390,252
+1.2%
1.71%
-6.3%
Q2 2016$60,487,000
+3.6%
3,351,104
+9.0%
1.82%
+1.4%
Q1 2016$58,365,000
-21.3%
3,073,470
+10.7%
1.80%
-20.1%
Q4 2015$74,158,000
+2.6%
2,777,464
-6.3%
2.25%
+10.8%
Q3 2015$72,289,000
+28.1%
2,962,656
+63.6%
2.03%
+42.3%
Q2 2015$56,436,0001,811,1661.43%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders